Cargando…
Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer
SIMPLE SUMMARY: Small-cell lung cancer (SCLC) is an aggressive malignancy with a high risk of recurrence and poor prognosis despite aggressive treatment. The use of immunotherapy has revolutionized the therapeutic landscape of SCLC with the introduction of novel, effective treatment options. Immune...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865814/ https://www.ncbi.nlm.nih.gov/pubmed/33572705 http://dx.doi.org/10.3390/cancers13030506 |